Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of the Tolerability of Lenalidomide and Low Dose Dexamethasone in Previously Treated Multiple Myeloma Patients With Impaired Renal Function

NCT00790842 is registered in ClinicalTrials.gov with PrECOG, LLC. as lead sponsor.

NCT NCT00790842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00790842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of the Tolerability of Lenalidomide and Low Dose Dexamethasone in Previously Treated Multiple Myeloma Patients With Impaired Renal Function
Lead sponsor
PrECOG, LLC.
Phase
Phase 1/2
Overall status
Terminated
Start date
January 21, 2009
Completion date
March 8, 2018
Enrollment
63 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, plasma cell neoplasm